Dublin, Jan. 28, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/kr66q6/pen_injection) has announced the addition of the "Pen Injection Devices" report to their offering.
User-friendly syringe and injection device designs and the availability of an increasing number of drugs in prefilled insertable and disposable cartridges are propelling the growth of pen injection devices for self-administration. The cost of biologicals such as recombinant proteins has created interest in pen injectors to reduce cost and waste associated with the handling of vial-packaged drugs. A second factor is the continued adoption of custom pen designs as a way of differentiating injectables developed for self-administration through product branding. These devices feature one or more user-friendly features to further the product's desirability relative to competing options.
What You Will Learn
- What injectable drugs are supplied in pen injection devices; what are the key market segments, market dynamics and market demographics?
- What are the therapeutic demand drivers and commercial pen products in key product segments?
- What are the design factors, material selection issues, technologies and market development issues?
- How big is the pen injection device market? How fast is it growing? What will it look like in five years?
- Who are the leading device and drug sector participants, their product development activities, business strategies, and corporate alliances and affiliations?
- What is the importance of pharma-device alliances and design partnerships on pen injection device commercialization and market access?
- What is the impact of wirelessly connected pen injection devices on patient care and market growth?
- What are the significant economic, technology, and regulatory factors affecting the market for pen injection devices?
Key Topics Covered:
1. Executive Summary
2. Injectable Drug Sector Market Dynamics
- The Injectable Drug Ecosystem
- Drug Classes and Devices
- Indications and Demand
- The Pen Injection Device Market
- Device Growth Factors
- Biological Drugs Proliferating
- Growth of Self-Administration
- Shifting Demographics
- Device Design Innovation
- Competitive Landscape
- Risk Factors
3. Pen Injection Device Design Factors
- Standardized Pen Platforms
- Custom Pen Designs
- Reusable Pens
- Prefilled Pen Cartridges
- Disposable Pens
- Dual Chamber Pens
- Variable vs Fixed Dosing
- Connected Pens
4. Important Pen-Delivered Drug Classes
- Antibodies
- Anticholinergics
- Dopamine Receptors
- Hematopoietics
- Human Growth Hormone
- Immune Modulators
- Insulins and Antihyperglycemics
- Parathyroid Hormone
- Reproductive Hormones
- Serotonin Antagonists
- Sympathomimetics
5. Pen Injectors - Therapeutic Sector Assessment
- Anemia
- Inflammatory Autoimmune Diseases
- Diabetes
- Emergency Medicine
- Hepatitis
- Hormone Replacement
- Osteoporosis
- Reproductive Health
- Other Commercial Pen Markets & Products
6. Market Factors
- Regulatory Considerations
- Patient Preferences and Compliance
- Managed Care Initiatives
- Private Labeling
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/kr66q6/pen_injection
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables , Needles and Syringes


United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks
Hyundai Takes Full Control of Boston Dynamics to Accelerate Humanoid Robot and AI Strategy
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List
Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 



